Puerarin, a major ingredient of GGT, has proven to suppress inflammatory mediator release by blocking NF-κB in lipopolysaccharide-induced peripheral blood mononuclear cells [40], decreasing to some extent the risk of SS. Here, NFKB1 is linked to synovial sarcoma.